Aprea Therapeutics (APRE) Misses Q3 EPS by 47c
Tweet
Share
E-mailGet Alerts APRE Hot Sheet
Join SI Premium – FREE
Aprea Therapeutics (NASDAQ: APRE) reported Q3 EPS of ($0.47). Revenue for the quarter came in at $1.84 million.
For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
- Business First Bancshares, Inc. (BFST) Tops Q2 EPS by 1c
- HomeTrust Bancshares, Inc. (HTB) Tops Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
